740809-75-0

Basic information

• Product Name: 7α-[6-(N-(2-hydroxyethyl)-diphenylphosphinamido)-hexan-1-yl]-estra-1,3,5(10)triene-3,17β-bis-2-tetrahydropyranyl ether
• Synonyms: 7α-[6-(N-(2-hydroxyethyl)-diphenylphosphinamido)-hexan-1-yl]-estra-1,3,5(10)triene-3,17β-bis-2-tetrahydropyranyl ether
• CAS NO: 740809-75-0
• Molecular Weight: 784.029
• Mol File: 740809-75-0.mol

Chemical Properties

• CAS DataBase Reference: 7α-[6-(N-(2-hydroxyethyl)-diphenylphosphinamido)-hexan-1-yl]-estra-1,3,5(10)triene-3,17β-bis-2-tetrahydropyranyl ether(CAS DataBase Reference)
• NIST Chemistry Reference: 7α-[6-(N-(2-hydroxyethyl)-diphenylphosphinamido)-hexan-1-yl]-estra-1,3,5(10)triene-3,17β-bis-2-tetrahydropyranyl ether(740809-75-0)
• EPA Substance Registry System: 7α-[6-(N-(2-hydroxyethyl)-diphenylphosphinamido)-hexan-1-yl]-estra-1,3,5(10)triene-3,17β-bis-2-tetrahydropyranyl ether(740809-75-0)

Safety Data

• Hazardous Substances Data: 740809-75-0(Hazardous Substances Data)

Upstream product

• 408512-82-3 3,17β-bis(2-tetrahydropyranyloxy)-7α-(5-hexen-1-yl)-estra-1,3,5(10)triene 
• 251322-01-7 3,17β-bis(2-tetrahydropyranyloxy)-7α-(5-hexen-1-yl)-estra-1,3,5(10)-triene-6-one 
• 251322-02-8 7α-(5-hexen-1-yl)estra-1,3,5(10)-triene-3,17β-diol 
• 122566-22-7 (8R,9S,13S,14S,17S)-13-Methyl-3,17-bis-(tetrahydro-pyran-2-yloxy)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-6-ol 
• 53573-82-3 3,17β-bis(2-tetrahydropyranyloxy)estra-1,3,5(10)-triene-6-one 
• 3589-91-1 3,17β-bis(2-tetrahydropyranyloxy)estra-1,3,5(10)-triene 
• 50-28-2 estradiol 
• 408512-84-5 3,17β-bis(2-tetrahydropyranyloxy)-7α-(6-bromohexan-1-yl)-estra-1,3,5(10)triene 
• 408512-83-4 6-((7R,13S,14S,17S)-13-methyl-3,17-bis((tetrahydro-2H-pyran-2-yl)oxy)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-7-yl)hexan-1-ol 
• 173042-73-4 2-(tert-butyldimethylsilanoxy)ethyl-diphenylphosphinamide 
• 408512-85-6 7α-[6-(N-(2-(tert-butyldimethylsilanyloxy)-ethyl)-diphenylphosphinamido)-hexan-1-yl]-estra-1,3,5(10)triene-3,17β-bis-2-tetrahydropyranyl ether 

Downstream Products

• 740809-76-1 C₆₀H₈₆N₃O₉PS 

Relevant articles and documents

Methods and compositions for treating cancer

The invention provides compounds and methods for treating cancer. Exemplary compounds are multi-functional compounds with two different moieties connected by a linker. Compounds of the invention can activate one or more pathways that result in the inhibit

Design, synthesis, and evaluation of estradiol-linked genotoxicants as anti-cancer agents

A series of bifunctional compounds was prepared consisting of 17β estradiol linked to a DNA damaging N,N-bis-(2-chloroethyl)aniline. The objective of our studies was to determine the characteristics of the linker that permitted both reaction with DNA and

A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cells

We describe a novel strategy to increase the selective toxicity of genotoxic compounds. The strategy involves the synthesis of bifunctional molecules capable of forming DNA adducts that have high affinity for specific proteins in target cells. It is propo